Background Up to 75% of people with serious mental illness (SMI) such as schizophrenia
and bipolar disorder have co‐occurring substance use disorders (dual diagnosis). Dual …

Background Given the great importance of treating patients with bipolar disorder, the aim of
this study was to compare the efficacy of aripiprazole with other second-generation …

Background: Co-occurring substance use disorders (SUDs) occur in as many as half to three
quarters of patients with severe mental disorders such as schizophrenia and bipolar …

Bipolar disorder (BD) is a chronic disorder which usually has its onset in early adulthood. At
one end of the spectrum is depression and at other is mania. Like many psychiatric …

Abstract The Side Effects of Drugs Annuals is a series of volumes in which the adverse
effects of drugs and adverse reactions to them are surveyed. The series supplements the …

Does the principal investigator, or do any research personnel who are responsible for the
design, conduct or reporting of this project or any of their family members (spouse or …

U ovom radu je ispitivano dejstvo dva novosintetisana arilpiperazinska D 2/5-HT 1A
dopaminergička/serotoninergička liganda, koji ispoljavaju neuroprotektivna svojstva in vitro …

Purpose The purpose of this review is to help policy makers and clinicians make informed
choices about the use of second generation antipsychotic agents. Given the prominent role …